Login to Your Account



Circassia Seeks Backers for Phase III Allergy Therapy Study

By Nuala Moran
Staff Writer

Wednesday, September 18, 2013
LONDON – Circassia Ltd. is looking for shareholders’ backing for a Phase III trial of its house dust mite allergy treatment after reporting positive results in a Phase II study, with subjects who received the most effective dose showing a significant reduction in symptoms of allergic rhinitis at one year.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription